Phase II and Biomarker Study of Cabozantinib in Metastatic Triple‐Negative Breast Cancer Patients
Tolaney, Sara M., Ziehr, David R., Guo, Hao, Ng, Mei R., Barry, William T., Higgins, Michaela J., Isakoff, Steven J., Brock, Jane E., Ivanova, Elena V., Paweletz, Cloud P., Demeo, Michelle K., Ramaiya, Nikhil H., Overmoyer, Beth A., Jain, Rakesh K., Winer, Eric P., Duda, Dan G.
Published in The oncologist (Dayton, Ohio) (01.01.2017)
Published in The oncologist (Dayton, Ohio) (01.01.2017)
Get full text
Journal Article
Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab
Filho, Otto Metzger, Viale, Giuseppe, Stein, Shayna, Trippa, Lorenzo, Yardley, Denise A, Mayer, Ingrid A, Abramson, Vandana G, Arteaga, Carlos L, Spring, Laura M, Waks, Adrienne G, Wrabel, Eileen, DeMeo, Michelle K, Bardia, Aditya, Dell'Orto, Patrizia, Russo, Leila, King, Tari A, Polyak, Kornelia, Michor, Franziska, Winer, Eric P, Krop, Ian E
Published in Cancer discovery (01.10.2021)
Published in Cancer discovery (01.10.2021)
Get full text
Journal Article
Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial)
Ruddy, Kathryn J., Zheng, Yue, Tayob, Nabihah, Hu, Jiani, Dang, Chau T., Yardley, Denise A., Isakoff, Steven J., Valero, Vicente V., Faggen, Meredith G., Mulvey, Therese M., Bose, Ron, Sella, Tal, Weckstein, Douglas J., Wolff, Antonio C., Reeder-Hayes, Katherine E., Rugo, Hope S., Ramaswamy, Bhuvaneswari, Zuckerman, Dan S., Hart, Lowell L., Gadi, Vijayakrishna K., Constantine, Michael, Cheng, Kit L., Briccetti, Frederick M., Schneider, Bryan P., Merrill Garrett, A., Kelly Marcom, P., Albain, Kathy S., DeFusco, Patricia A., Tung, Nadine M., Ardman, Blair M., Nanda, Rita, Jankowitz, Rachel C., Rimawi, Mothaffar, Abramson, Vandana, Pohlmann, Paula R., Van Poznak, Catherine, Forero-Torres, Andres, Liu, Minetta C., Rosenberg, Shoshana, DeMeo, Michelle K., Burstein, Harold J., Winer, Eric P., Krop, Ian E., Partridge, Ann H., Tolaney, Sara M.
Published in Breast cancer research and treatment (01.08.2021)
Published in Breast cancer research and treatment (01.08.2021)
Get full text
Journal Article
Phase II and Biomarker Study of Cabozantinib in Metastatic Triple‐Negative Breast Cancer Patients
Tolaney, Sara M., Ziehr, David R., Guo, Hao, Ng, Mei R., Barry, William T., Higgins, Michaela J., Isakoff, Steven J., Brock, Jane E., Ivanova, Elena V., Paweletz, Cloud P., Demeo, Michelle K., Ramaiya, Nikhil H., Overmoyer, Beth A., Jain, Rakesh K., Winer, Eric P., Duda, Dan G.
Published in The oncologist (Dayton, Ohio) (01.08.2021)
Published in The oncologist (Dayton, Ohio) (01.08.2021)
Get full text
Journal Article
Erratum
Tolaney, Sara M, Ziehr, David R, Guo, Hao, Ng, Mei R, Barry, William T, Higgins, Michaela J, Isakoff, Steven J, Brock, Jane E, Ivanova, Elena V, Paweletz, Cloud P, Demeo, Michelle K, Ramaiya, Nikhil H, Overmoyer, Beth A, Jain, Rakesh K, Winer, Eric P, Duda, Dan G
Published in The oncologist (Dayton, Ohio) (01.08.2021)
Get full text
Published in The oncologist (Dayton, Ohio) (01.08.2021)
Journal Article
Erratum
Tolaney, Sara M, Ziehr, David R, Guo, Hao, Ng, Mei R, Barry, William T, Higgins, Michaela J, Isakoff, Steven J, Brock, Jane E, Ivanova, Elena V, Paweletz, Cloud P, Demeo, Michelle K, Ramaiya, Nikhil H, Overmoyer, Beth A, Jain, Rakesh K, Winer, Eric P, Duda, Dan G
Published in The oncologist (Dayton, Ohio) (01.08.2021)
Get full text
Published in The oncologist (Dayton, Ohio) (01.08.2021)
Journal Article
Abstract P2-13-02: Chemotherapy-related amenorrhea (CRA) after adjuvant trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT trial)
Ruddy, Kathryn J., Trippa, Lorenzo, Hu, Jiani, Barry, William T., Dang, Chau T., Yardley, Denise A., Isakoff, Steven J., Valero, Vincente V., Faggen, Meredith G., Mulvey, Therese M., Bose, Ron, Weckstein, Douglas J., Wolff, Antonio C., Reeder-Hayes, Katherine E., Rugo, Hope S., Ramaswamy, Bhuvaneswari, Zuckerman, Dan S., Hart, Lowell L., Gadi, Vijayakrishna K., Constantine, Michael, Cheng, Kit L., Briccetti, Frederick M., Schneider, Bryan P., Garrett, A. Merrill, Marcom, P. Kelly, Albain, Kathy S., DeFusco, Patricia A., Tung, Nadine M., Ardman, Blair M., Nanda, Rita, Jankowitz, Rachel C., DeMeo, Michelle K., Burstein, Harold J., Winer, Eric P., Krop, Ian E., Partridge, Ann H., Tolaney, Sara M.
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Get full text
Journal Article
Abstract 3707: Characterization of estrogen receptor expression on CTCs during CDK4/6i treatment in HR+/HER2- metastatic breast cancer: Results from the PACE phase II study
Serafini, Mara Serena, Reduzzi, Carolina, Gerratana, Lorenzo, Jeselsohn, Rinath, Mahtani, Reshma L., Ma, Cynthia X., DeMichele, Angela, Meisel, Jane Lowe, Miller, Kathy D., Abdou, Yara, Riley, Elizabeth C., Qamar, Rubina, Sharma, Priyanka, Reid, Sonya, Burstein, Harold J., Tolaney, Sara M., DeMeo, Michelle K., Liu, Yuan, Gauthier, Eric, Ren, Yue, Regan, Meredith M., Liu, Huiping, Mayer, Erica L., Cristofanilli, Massimo
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article
Abstract GS3-06: GS3-06 Palbociclib After CDK4/6i and Endocrine Therapy (PACE): A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab for Endocrine Pre-treated ER+/HER2- Metastatic Breast Cancer
Mayer, Erica L., Ren, Yue, Wagle, Nikhil, Mahtani, Reshma, Ma, Cynthia, DeMichele, Angela, Cristofanilli, Massimo, Meisel, Jane, Miller, Kathy D., Jolly, Trevor, Riley, Elizabeth, Qamar, Rubina, Sharma, Priyanka, Reid, Sonya, Sinclair, Natalie, Faggen, Meredith, Block, Caroline, Ko, Naomi, Partridge, Ann, Chen, Wendy Y., DeMeo, Michelle K., Attaya, Victoria, Okpoebo, Amanda, Liu, Yuan, Gauthier, Eric, Burstein, Harold, Regan, Meredith, Tolaney, Sara
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Get full text
Journal Article
Abstract PD18-02: Adjuvant Paclitaxel and Trastuzumab Trial (APT) for Node-Negative, Human Epidermal Growth Factor Receptor 2–Positive (HER2+) Breast Cancer: final 10-year analysis
Tolaney, Sara, Tarantino, Paolo, Graham, Noah, Tayob, Nabihah, Dang, Chau T, Yardley, Denise, Moy, Beverly, Marcom, Paul K., Albain, Kathy S., Rugo, Hope, Ellis, Matthew, Shapira, Iuliana, Wolff, Antonio C., Carey, Lisa, Barroso-Sousa, Romualdo, DeMeo, Michelle K., DiLullo, Molly K., Partridge, Ann, Waks, Adrienne, Hudis, Clifford, Krop, Ian, Burstein, Harold, Prat, Aleix, Winer, Eric
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Get full text
Journal Article
Abstract PD18-01: Adjuvant Trastuzumab Emtansine Versus Paclitaxel plus Trastuzumab for Stage I HER2+ Breast Cancer: 5-year results and correlative analyses from ATEMPT (TBCRC033)
Tarantino, Paolo, Tayob, Nabihah, Dang, Chau T, Yardley, Denise, Isakoff, Steven J., Valero, Vicente, Faggen, Meredith, Mulvey, Therese, Bose, Ron, Weckstein, Douglas, Wolff, Antonio C., Reeder-Hayes, Katherine, Rugo, Hope, Ramaswamy, Bhuvaneswari, Zuckerman, Dan, Hart, Lowell, Gadi, Vijayakrishna K., Constantine, Michael, Cheng, Kit, Garrett, Audrey Merrill, Marcom, Paul K., Albain, Kathy S., DeFusco, Patricia, Tung, Nadine, Ardman, Blair, Nanda, Rita, Jankowitz, Rachel C., Rimawi, Mothaffar, Abramson, Vandana, Pohlmann, Paula R., Van Poznak, Catherine, Forero-Torres, Andres, Liu, Minetta C., Ruddy, Kathryn, Zheng, Yue, Barroso-Sousa, Romualdo, Waks, Adrienne, DeMeo, Michelle K., DiLullo, Molly K., Curigliano, Giuseppe, Burstein, Harold, Partridge, Ann, Winer, Eric, Viale, Giuseppe, Hui, Winnie, Mittendorf, Elizabeth A., Schneider, Bryan P., Prat, Aleix, Krop, Ian, Tolaney, Sara
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Get full text
Journal Article